LEADER 02671nam  2200613 a 450 
001 9910958009203321
005 20251117065754.0
010   $a1-61728-480-7
035   $a(CKB)2670000000090500
035   $a(EBL)3020935
035   $a(SSID)ssj0000470344
035   $a(PQKBManifestationID)11312432
035   $a(PQKBTitleCode)TC0000470344
035   $a(PQKBWorkID)10411156
035   $a(PQKB)11213554
035   $a(MiAaPQ)EBC3020935
035   $a(Au-PeEL)EBL3020935
035   $a(CaPaEBR)ebr10681073
035   $a(OCoLC)923664583
035   $a(BIP)30904820
035   $a(EXLCZ)992670000000090500
100   $a20100616d2010      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aInsulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) /$fMasato Yoneda ... [et al.]
205   $a1st ed.
210   $aNew York $cNova Biomedical Books$dc2010
215   $a1 online resource (64 p.)
225 1 $aMetabolic diseases--laboratory and clinical research
225 1 $aNovinka
300   $aDescription based upon print version of record.
311 08$a1-61668-927-7 
320   $aIncludes bibliographical references and index.
327   $aNAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions.
330   $aThe liver is the first organ to receive nutrients that enter the body via the intestines after a meal, and this organ plays a pivotal role in energy metabolism. This book reviews evidence concerning insulin resistance and NAFLD/NASH as a step towards a comprehensive understanding of the pathophysiology and treatment of NAFLD/NASH.
410  0$aMetabolic diseases--laboratory and clinical research series.
410  0$aNovinka (Series)
606   $aFatty liver
606   $aInsulin resistance
615  0$aFatty liver.
615  0$aInsulin resistance.
676   $a616.3/62
700   $aYoneda$b Masato$01868116
701   $aYoneda$b Masato$01868116
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910958009203321
996   $aInsulin resistance and nonalcoholic fatty liver disease (NAFLD)$94475948
997   $aUNINA